The Davila Lab aims to understand the cellular and molecular signals that promote the genteration of potent and long-lasting tumor-specific T cell responses. Research is not focused on any single cancer type, and instead on immunotherapeutic strategies applicable across various tumor types.
The Wilky lab investigates the sarcoma immune microenbironment and immunotherapy combinations by studying the interaction between sarcomas, bone cancers, and soft tissues with the immune system, aiming to overcome resistance using combinations of immune-boosting therapies with chemotherapies.
The Sabaawy lab is interested in precision medicine for cancer and aims to identify stem cell targets, genetic modifiers, and smoll molecule inhibitors that will ultimately improve survival rates for cancer patients.
The Schenk lab focuses on the immune cells within the tumor and how specific subtypes can contribute to treatment resistance and ultimately aims to use their findings to improve therapy for patients with lung cancer.
.png?sfvrsn=136c09bb_0 "Wilky, Breelyn")